One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Expert consensus recommendations for improving and standardising the assessment of patients with generalised myasthenia gravis
Andreas Meisel, Francesco Saccà , Jennifer Spillane, John Vissing, the MG Collegium Sub-committee
doi : 10.1111/ene.16280
Management of seizures in patients with primary mitochondrial diseases: consensus statement from the InterERNs Mitochondrial Working Group
Michelangelo Mancuso, Maria T. Papadopoulou, Yi Shiau Ng, Anna Ardissone, Marcello Bellusci, Enrico Bertini, Lidia Di Vito, Teresinha Evangelista, Carmen Fons, Omar Hikmat, Rita Horvath, Thomas Klopstock, Cornelia Kornblum, Costanza Lamperti, Laura Licchetta, Maria Judit Molnar, Kristin N. Varhaug, Mar O'Callaghan, Ronit M. Pressler, Manuel Schiff, Serenella Servidei, Nora Szabo, Gráinne S. Gorman, J Helen Cross, Shamima Rahman
doi : 10.1111/ene.16275
Association of diabetes mellitus with dementia- and non-dementia-related mortality amongst women: a secondary competing risks analysis of the California Teachers Study
Cathleen Morgan, Bradon Annegers, Matthew K. Taylor, Sara Shuger Fox, Tyler J. Titcomb
doi : 10.1111/ene.16294
Symptom-based staging for logopenic variant primary progressive aphasia
Chris J. D. Hardy, Cathleen Taylor-Rubin, Beatrice Taylor, Emma Harding, Aida Suarez Gonzalez, Jessica Jiang, Laura Thompson, Rachel Kingma, Anthipa Chokesuwattanaskul, Ffion Walker, Suzie Barker, Emilie Brotherhood, Claire Waddington, Olivia Wood, Nikki Zimmermann, Nuriye Kupeli, Keir X. X. Yong, Paul M. Camic, Joshua Stott, Charles R. Marshall, Neil P. Oxtoby, Jonathan D. Rohrer, Frankie O'Shea, Anna Volkmer, Sebastian J. Crutch, Jason D. Warren
doi : 10.1111/ene.16304
Reduction in short interval intracortical inhibition from the early stage reflects the pathophysiology in amyotrophic lateral sclerosis: A meta-analysis study
Mana Higashihara, Nathan Pavey, Parvathi Menon, Mehdi van den Bos, Kazumoto Shibuya, Satoshi Kuwabara, Matthew C. Kiernan, Masayoshi Koinuma, Steve Vucic
doi : 10.1111/ene.16281
Compassionate mind training for people with Parkinson's disease: A pilot study and predictors of response
Silvia Della Morte, Elena Berti, Carolina Lalli, Nicola Modugno, Francesca Morgante, Anette Schrag, Elena Makovac, Lucia Ricciardi
doi : 10.1111/ene.16286
Service delivery in acute ischemic stroke patients: Does sex matter?
Friedrich Medlin, Davide Strambo, Dimitris Lambrou, Valeria Caso, Patrik Michel
doi : 10.1111/ene.16287
Lower serum uric acid to serum creatinine ratio as a predictor of poor functional outcome after mechanical thrombectomy in acute ischaemic stroke
Jinghan Xu, Xin Jiang, Qian Liu, Jiaxin Liu, Jinghuan Fang, Li He
doi : 10.1111/ene.16296
Prevalence, recovery and phenotype of dysphagia in patients with ischaemic cerebellar stroke
Jan Hendrik Schaefer, Felix Luft, Alexander Seiler, Elena Harborth, Sara Kaffenberger, Christoph Polkowski, Christian Foerch, Sriramya Lapa
doi : 10.1111/ene.16303
Treatment of post-treatment Lyme disease symptoms—a systematic review
Rick Dersch, Gabriel Torbahn, Sebastian Rauer
doi : 10.1111/ene.16293
Real-world persistence of multiple sclerosis disease-modifying therapies
Emma C. Tallantyre, Ruth Dobson, Joseph L. J. Froud, Frederika A. St John, Valerie M. Anderson, Tarunya Arun, Lauren Buckley, Nikos Evangelou, Helen L. Ford, Ian Galea, Sumi George, Orla M. Gray, Aimee M. Hibbert, Mo Hu, Stella E. Hughes, Gillian Ingram, Seema Kalra, Chia-Hui E. Lim, Joela T. M. Mathews, Gavin V. McDonnell, Naomi Mescall, Sam Norris, Stephen J. Ramsay, Claire M. Rice, Melanie J. Russell, Marianne J. Shawe-Taylor, Thomas E. Williams, Katharine E. Harding, Neil P. Robertson
doi : 10.1111/ene.16289
Clinical effectiveness of coronavirus disease 2019 vaccination in patients with multiple sclerosis stratified by disease-modifying treatment
Marijke De Troyer, Ann Van Remoortel, Jeroen Van Schependom, Laetitia Della Faille, Marie B. D'hooghe, Gertjan Peeters, Guy Nagels, Miguel D'haeseleer
doi : 10.1111/ene.16300
Manifestations of X-linked pyruvate dehydrogenase complex deficiency in female PDHA1 carriers
Antri Savvidou, Kalliopi Sofou, Erik A. Eklund, Johan Aronsson, Niklas Darin
doi : 10.1111/ene.16283
Rate and characteristics of inflammatory neuropathies associated with brentuximab vedotin therapy
Arthur Matthys, Benjamin Bardel, Fabien Le Bras, Alain Créange, Tarik Nordine, Romain Gounot, Saskia Ingen-Housz-Oro, Muriel Carvalho, Jean-Pascal Lefaucheur, Corinne Haioun, Violaine Planté-Bordeneuve, Thierry Gendre
doi : 10.1111/ene.16285
Antiganglioside antibody frequency in routine clinical care settings
Niklas Giesche, Samuel Tobias Böhm-Gonzalez, Benedict Kleiser, Markus C. Kowarik, Evelyn Dubois, Elke Stransky, Marcel Armbruster, Alexander Grimm, Justus Marquetand
doi : 10.1111/ene.16290
Prevention of axonal loss after immediate dosage titration of immunoglobulin in multifocal motor neuropathy
Ali Al-Zuhairy, Johannes Jakobsen, Christian Krarup
doi : 10.1111/ene.16305
Lessons for future clinical trials in adults with Becker muscular dystrophy: Disease progression detected by muscle magnetic resonance imaging, clinical and patient-reported outcome measures
Bram De Wel, Louise Iterbeke, Lotte Huysmans, Ronald Peeters, Veerle Goosens, Nicolas Dubuisson, Peter van den Bergh, Vinciane Van Parijs, Gauthier Remiche, Liesbeth De Waele, Frederik Maes, Patrick Dupont, Kristl G. Claeys
doi : 10.1111/ene.16282
Real-life effectiveness 1 year after switching to avalglucosidase alfa in late-onset Pompe disease patients worsening on alglucosidase alfa therapy: A French cohort study
Céline Tard, Françoise Bouhour, Maud Michaud, Stephane Beltran, Maxime Fournier, Florence Demurger, Emmeline Lagrange, Sylvain Nollet, Sabrina Sacconi, Jean-Baptiste Noury, Armelle Magot, Pascal Cintas, Dimitri Renard, Joëlle Deibener-Kaminsky, Claire Lefeuvre, Jean-Baptiste Davion, Emmanuelle Salort-Campana, Azzeddine Arrassi, Nadjib Taouagh, Marco Spinazzi, Pompe Study Group, Shahram Attarian, Pascal Laforêt
doi : 10.1111/ene.16292
Structural correlations between brain magnetic resonance image-derived phenotypes and retinal neuroanatomy
Zihan Sun, Bing Zhang, Stephen Smith, Denize Atan, Anthony P. Khawaja, Kelsey V. Stuart, Robert N. Luben, Mahantesh I. Biradar, Thomas McGillivray, Praveen J. Patel, Peng T. Khaw, Axel Petzold, Paul J. Foster, the UK Biobank Eye and Vision Consortium
doi : 10.1111/ene.16288
Quantifying neurodegeneration of the cervical cord and brain in degenerative cervical myelopathy: A multicentre study using quantitative magnetic resonance imaging
Patrick Freund, Viveka Boller, Tim M. Emmenegger, Muhammad Akbar, Markus Hupp, Nikolai Pfender, Claudia Angela Michela Gandini Wheeler-Kingshott, Julien Cohen-Adad, Michael G. Fehlings, Armin Curt, Maryam Seif
doi : 10.1111/ene.16297
Factors affecting the topography of nitrous oxide-induced neurological complications
Eva Sole Cruz, Etienne Fortanier, Frederic Hilezian, Adil Maarouf, Clémence Boutière, Sarah Demortière, Audrey Rico, Emilien Delmont, Jean Pelletier, Shahram Attarian, Bertrand Audoin
doi : 10.1111/ene.16291
Optical coherence tomography assessment of disease activity in cryopyrin-associated periodic syndrome
E. Mulazzani, L. Böhm, T. Christmann, M. Krumbholz, T. Kümpfel, J. Havla
doi : 10.1111/ene.16301
Overcoming therapeutic challenges: Successful management of a supposedly triple seronegative, refractory generalized myasthenia gravis patient with efgartigimod
Benedetta Sorrenti, Christian Laurini, Luca Bosco, Camilla Mirella Maria Strano, Marina Scarlato, Matteo Gastaldi, Massimo Filippi, Stefano Carlo Previtali, Yuri Matteo Falzone
doi : 10.1111/ene.16306
Clinical and neuroimaging phenotypes of autoimmune glial fibrillary acidic protein astrocytopathy: A systematic review and meta-analysis
Caroline Hagbohm, Russell Ouellette, Eoin P. Flanagan, Dagur I. Jonsson, Fredrik Piehl, Brenda Banwell, Ronny Wickström, Ellen Iacobaeus, Tobias Granberg, Benjamin V. Ineichen
doi : 10.1111/ene.16284
Beyond T cell toxicity – Intrathecal chemokine CXCL13 indicating B cell involvement in immune-related adverse events following checkpoint inhibition: A two-case series and literature review
doi : 10.1111/ene.16279
Type 2 diabetes mellitus duration and subsequent risk of Alzheimer disease
Tomoyuki Kawada
doi : 10.1111/ene.16274
Headaches during/after SARS-CoV-2 infection/vaccination can be primary and secondary as well as acute and chronic
Josef Finsterer, Sounira Mehri
doi : 10.1111/ene.16307
Reply to the letter: Headaches during/after SARS-CoV-2 infection/vaccination can be primary and secondary as well as acute and chronic, by Finsterer J and Mehri S
Dimos-Dimtirios D. Mitsikostas, Edoardo Caronna, Marina De Tommaso, Christina I. Deligianni, Esme Ekizoglu, Hayrunnisa Bolay, Carl H. Göbel, Espen Saxhaug Kristoffersen, Christian Lampl, Elena Moro, Patricia Pozo-Rosich, Johann Sellner, Gisela Terwindt, Pablo Irimia-Sieira
doi : 10.1111/ene.16308
